Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Losartan in hypertension
NCT00882440Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Dec 1990
- Primary completion
- Aug 1991
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of losartan in hypertension (HTN) (7 arms), sponsored by Merck & Co. Primary endpoint: Mean Change From Baseline in Trough Supine Diastolic Blood Pressure (SuDBP) at 8 weeks. Started Dec 1990; status: completed.
02
Drugs
losartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00882440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00882440.